V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10453061 | 10034359 | 1.57 | 78 | Disease modification (D) | 2019-04-27 | 2019-05-14 | Capecitabine | 02 | N | CAPECITABINE | 101826173 |
| 10453068 | 10034360 | 1.55 | 82 | null | 2019-04-07 | 2019-04-09 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100100734 |
| 10453084 | 10034361 | 1.7 | 73.8 | 02 | 2020-10-21 | 2020-10-26 | IBRUTINIB | 02 | N | IBRUTINIB | 101845239 |
| 10453096 | 10034362 | 1.63 | 71.5 | 03 | 2015-06-29 | 2015-07-12 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101675359 |
| 10453103 | 10034363 | 1.45 | 78 | 03 | 2017-11-11 | 2017-11-18 | Rituximab | 02 | N | RITUXIMAB | 100099291 |
| 10453111 | 10034364 | null | 76.8 | Curative (C) | 2022-02-23 | 2022-03-01 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100889782 |
| 10453116 | 10034365 | 1.6 | null | null | 2021-12-25 | 2021-12-25 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101271957 |
| 10453117 | 10034366 | null | 72 | Palliative (P) | 2016-11-18 | 2016-11-18 | IBRUTINIB | 02 | N | IBRUTINIB | 100741816 |
| 10453127 | 10034367 | 1.56 | 90.9 | null | 2014-12-02 | 2014-12-28 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101501546 |
| 10453138 | 10034368 | 0 | 92.18 | Palliative (P) | 2019-06-25 | 2019-06-25 | IBRUTINIB | 02 | N | IBRUTINIB | 101265129 |
| 10453160 | 10034369 | 1.72 | 80.55 | Adjuvant (A) | 2017-09-07 | 2017-10-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101607092 |
| 10453161 | 10034370 | 1.55 | 0 | 02 | 2022-04-14 | 2022-04-28 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100340722 |
| 10453163 | 10034371 | 1.57 | 107.4 | null | 2019-09-21 | 2019-09-21 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101207366 |
| 10453168 | 10034372 | null | 69.7 | Palliative (P) | 2021-10-03 | 2021-10-07 | Rituximab | 02 | N | RITUXIMAB | 100974453 |
| 10453180 | 10034373 | 1.7 | 78.8 | Neo-adjuvant (N) | 2021-09-04 | 2021-09-04 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100185645 |
| 10453189 | 10034374 | 1.69 | 107.2 | Palliative (P) | 2016-12-13 | 2017-01-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101667492 |
| 10453191 | 10034375 | 1.67 | 72 | Palliative (P) | 2014-01-17 | 2014-01-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100717353 |
| 10453192 | 10034376 | null | 81 | Curative (C) | 2021-04-09 | 2021-04-09 | IBRUTINIB | 02 | N | IBRUTINIB | 101580873 |
| 10453218 | 10034377 | 1.5 | 79.2 | Palliative (P) | 2017-04-13 | 2017-04-13 | IBRUTINIB | 02 | N | IBRUTINIB | 101723675 |
| 10453226 | 10034378 | 1.6 | 64.1 | Adjuvant (A) | 2019-05-18 | 2019-05-23 | IBRUTINIB | 02 | N | IBRUTINIB | 101691332 |
| 10453227 | 10034379 | 1.8 | 78 | null | 2021-04-25 | 2021-04-30 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101487094 |
| 10453233 | 10034380 | 1.62 | 81 | Palliative (P) | 2020-01-01 | 2020-01-01 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101137810 |
| 10453235 | 10034381 | 1.7 | 105 | Adjuvant (A) | 2015-06-26 | 2015-07-18 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101398895 |
| 10453274 | 10034382 | 1.76 | 71 | Adjuvant (A) | 2016-03-27 | 2016-04-06 | Capecitabine + Oxaliplatin 14day | 02 | N | DOCETAXEL | 100527656 |
| 10453282 | 10034383 | 1.86 | 80 | null | 2021-07-14 | 2021-07-29 | Capecitabine | 02 | null | CAPECITABINE | 100775540 |
| 10453283 | 10034384 | 1.79 | 73 | null | 2021-10-10 | 2021-10-16 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101640592 |
| 10453284 | 10034385 | 1.52 | 90 | Curative (C) | 2018-06-12 | 2018-07-04 | Capecitabine | 02 | N | CAPECITABINE | 100617629 |
| 10453318 | 10034386 | 1.76 | 82 | Palliative (P) | 2019-02-16 | 2019-02-16 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100249440 |
| 10453325 | 10034387 | null | 83.6 | Neo-adjuvant (N) | 2020-02-01 | 2020-02-01 | IBRUTINIB | 02 | N | IBRUTINIB | 101504340 |
| 10453337 | 10034388 | 1.79 | 84 | Palliative (P) | 2017-10-02 | 2017-10-02 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101456646 |
| 10453385 | 10034389 | 0 | 101.9 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-14 | Rituximab | 02 | null | RITUXIMAB | 101520898 |
| 10453389 | 10034390 | 1.77 | 77 | Palliative (P) | 2020-04-03 | 2020-04-16 | Capecitabine | 02 | N | CAPECITABINE | 101308217 |
| 10453406 | 10034391 | 1.65 | 63.2 | Neo-adjuvant (N) | 2021-06-10 | 2021-06-13 | Rituximab | 02 | null | RITUXIMAB | 100975674 |
| 10453423 | 10034392 | 1.83 | 95 | null | 2021-07-19 | 2021-07-29 | Capecitabine | 02 | null | CAPECITABINE | 100227592 |
| 10453460 | 10034393 | 1.63 | 80.3 | null | 2021-08-21 | 2021-09-18 | Rituximab (Maintenance) | 02 | null | RITUXIMAB | 101356823 |
| 10453473 | 10034394 | 1.53 | 54.6 | null | 2020-08-20 | 2020-08-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100360830 |
| 10453480 | 10034395 | 1.76 | 63.2 | 03 | 2018-07-11 | 2018-08-02 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100707396 |
| 10453495 | 10034396 | 1.82 | 81.8 | null | 2021-11-23 | 2021-12-13 | Rituximab | 02 | null | RITUXIMAB | 100674521 |
| 10453508 | 10034397 | 1.66 | 96.4 | Not known (9) | null | 2018-09-07 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100512472 |
| 10453522 | 10034398 | 1.75 | 74.5 | null | null | 2020-08-24 | Capecitabine + Oxaliplatin 14day | 02 | null | PEMBROLIZUMAB | 100690649 |
| 10453576 | 10034399 | 1.8 | 90 | 03 | null | 2018-06-18 | Capecitabine | 02 | N | CAPECITABINE | 100892917 |
| 10453586 | 10034400 | 1.58 | 50.7 | Palliative (P) | 2019-06-29 | 2019-07-11 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE | 101671029 |
| 10453592 | 10034401 | null | 70 | Palliative (P) | 2016-03-16 | 2016-03-17 | IBRUTINIB | 02 | Y | IBRUTINIB | 101436597 |
| 10453595 | 10034402 | 1.85 | 75 | Curative (C) | 2019-04-01 | 2019-04-01 | Capecitabine + Oxaliplatin 14day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101029948 |
| 10453602 | 10034403 | 0 | 62 | Palliative (P) | 2019-03-22 | 2019-04-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101261065 |
| 10453625 | 10034404 | 1.71 | 107.2 | Curative (C) | 2021-05-26 | 2021-06-02 | Rituximab | 02 | N | RITUXIMAB | 100358003 |
| 10453640 | 10034405 | 1.68 | 64.4 | Palliative (P) | 2017-06-12 | 2017-06-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100676531 |
| 10453643 | 10034406 | 1.63 | 73.7 | Palliative (P) | 2019-12-05 | 2019-12-19 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100936739 |
| 10453660 | 10034407 | 1.75 | 89 | Palliative (P) | 2016-03-08 | 2016-04-02 | Docetaxel | N | N | DOCETAXEL | 101746091 |
| 10453670 | 10034408 | 1.61 | 88.3 | 03 | 2020-07-03 | 2020-07-07 | PEMBROLIZUMAB | 02 | Y | PEMBROLIZUMAB | 101132347 |